Jay M. Moyes's Insider Trades & SAST Disclosures
Jay M. Moyes's most recent trade in BioCardia Inc. was a trade of 829 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jay M. Moyes.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 829 | 3,573 | - | - | Stock Option (right to buy) | |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 27,000 | 48,322 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Sale of securities on an exchange or to another person at price $ 3.34 per share. | 13 Jun 2024 | 22,000 | 21,322 (0%) | 0% | 3.3 | 73,467 | Common Stock |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 27,000 | 43,322 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Sale of securities on an exchange or to another person at price $ 3.45 per share. | 13 Jun 2023 | 22,000 | 16,322 (0%) | 0% | 3.5 | 75,970 | Common Stock |
| Sera Prognostics Inc - Ord... | Jay M. Moyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 51,800 | 51,800 | - | - | Stock Option (right to buy) | |
| Sera Prognostics Inc - Ord... | Jay M. Moyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 32,800 | 35,630 | - | 0 | Class A Common Stock | |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Sale of securities on an exchange or to another person at price $ 2.64 per share. | 16 Jun 2022 | 22,858 | 38,322 (0%) | 0% | 2.6 | 60,370 | Common Stock |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 27,000 | 61,180 (0%) | 0% | 0 | Common Stock | |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 12,434 | 28,789 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
| Sera Prognostics Inc - Ord... | Jay M. Moyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 168,275 | 168,275 | - | - | Stock Option (right to buy) | |
| Sera Prognostics Inc - Ord... | Jay M. Moyes | Chief Financial Officer | 19 Jul 2021 | 2,455 | 0 | - | - | Series A-2 Preferred Stock | ||
| Sera Prognostics Inc - Ord... | Jay M. Moyes | Chief Financial Officer | 19 Jul 2021 | 2,455 | 2,455 | - | - | Class A Common Stock | ||
| Sera Prognostics Inc - Ord... | Jay M. Moyes | Chief Financial Officer | 19 Jul 2021 | 375 | 2,830 | - | - | Class A Common Stock | ||
| Sera Prognostics Inc - Ord... | Jay M. Moyes | Chief Financial Officer | 19 Jul 2021 | 375 | 0 | - | - | Series B-1 Preferred Stock | ||
| Puma Biotechnology Inc | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 27,858 | 34,180 (0%) | 0% | 0 | Common Stock | |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 12,434 | 16,355 | - | - | Stock Option (right to buy) | |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Sale of securities on an exchange or to another person at price $ 11.36 per share. | 10 Jun 2021 | 25,248 | 6,322 (0%) | 0% | 11.4 | 286,860 | Common Stock |
| Achieve Life Sciences Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 3,750 | 3,750 | - | - | Stock Option (right to buy) | |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 3,456 | 54,267 (0%) | 0% | 0 | Common Stock | |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 3,750 | 44,261 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 16 Sep 2020 | 9,703 | 31,570 (0%) | 0% | 10 | 97,030 | COMMON STOCK |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 3,750 | 40,511 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 16 Jun 2020 | 9,720 | 41,273 (0%) | 0% | 9.5 | 92,340 | COMMON STOCK |
| Puma Biotechnology Inc | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 25,748 | 50,993 (0%) | 0% | 0 | COMMON STOCK | |
| Achieve Life Sciences Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2020 | 22,000 | 22,000 | - | - | Stock Option (right to buy) | |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2020 | 8,800 | 36,761 (0%) | 0% | 0 | Common Stock | |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 20,250 | 24,211 (0%) | 0% | 0 | Common Stock | |
| BioCardia Inc. | Jay M. Moyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 3,750 | 27,961 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges